Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
arm soreness; general fatigue; not feeling well; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in arm in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm soreness), fatigability generalized (Verbatim: general fatigue) and feeling unwell (Verbatim: not feeling well). The outcome of the pain in arm, fatigability generalized and feeling unwell were not reported. It was unknown if the reporter considered the pain in arm, fatigability generalized and feeling unwell to be related to Shingrix. It was unknown if the company considered the pain in arm, fatigability generalized and feeling unwell to be related to Shingrix. Additional Information: GSK receipt date: 11-AUG-2025 A female patient has had dose 1 of Shingrix. She reported not feeling well for the evening after the shot. She had arm soreness and general fatigue.; Sender's Comments: US-GSK-US2025AMR105842:Same reporter/ Case for reporter husband